Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 5/2011

01.10.2011 | Short Research Report

Unnecessary use of antibiotics for inpatient children with pneumonia in two counties of rural China

verfasst von: Xiaoyun Liang, Chenggang Jin, Li Wang, Lian Wei, Goran Tomson, Clas Rehnberg, Rolf Wahlstrom, Max Petzold

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective To assess unnecessary use and cost of antibiotics for inpatient care for children under 14 years of age with pneumonia, and to identify the cost distribution in relation to different socio-economic status. Setting The study was hospital-based and cross-sectional. Method Between July 2007 and June 2008, 226 participants were interviewed in two county hospitals and three township health centers in two counties in rural China. The healthcare facilities provided medical and financial records for all study participants. Appropriateness of antibiotic treatment was assessed, in accordance with guidelines, by a paediatrician from a university teaching hospital, who reviewed all medical records. The cost of unnecessary antibiotics was based on the health facilities’ price lists. Results Unnecessary antibiotic prescriptions occurred in 43% of all patients. The median unnecessary cost of antibiotics was 40 RMB yuan (IQR: 22–100), and this extra cost increased the financial burden for the pneumonia inpatients by 18%. There were no statistically significant differences related to socio-economic categories for unnecessary antibiotics cost (F = 1.43, P = 0.2444). Conclusion Unnecessary prescribing of antibiotics use laid an extra burden on children with pneumonia at inpatient care. Implications for policy and practice might be considered regarding incentives, guidelines and training for health care providers.
Literatur
1.
Zurück zum Zitat Cars O, Hogberg LD, Murray M, Nordberg O, Sivaraman S, Lundborg CS, et al. Meeting the challenge of antibiotic resistance. Br Med J. 2008;337:a1438.CrossRef Cars O, Hogberg LD, Murray M, Nordberg O, Sivaraman S, Lundborg CS, et al. Meeting the challenge of antibiotic resistance. Br Med J. 2008;337:a1438.CrossRef
2.
Zurück zum Zitat WHO. The world health report 2007: a safer future: global public health security in the 21st century. Geneva: WHO Press; 2007. WHO. The world health report 2007: a safer future: global public health security in the 21st century. Geneva: WHO Press; 2007.
3.
Zurück zum Zitat Reynolds L, McKee M. Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy. 2009;90(1):32–6.PubMedCrossRef Reynolds L, McKee M. Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy. 2009;90(1):32–6.PubMedCrossRef
4.
Zurück zum Zitat Hu S, Liu X, Peng Y. Assessment of antibiotic prescription in hospitalised patients at a Chinese university hospital. J Infect. 2003;46(3):161–3.PubMedCrossRef Hu S, Liu X, Peng Y. Assessment of antibiotic prescription in hospitalised patients at a Chinese university hospital. J Infect. 2003;46(3):161–3.PubMedCrossRef
5.
Zurück zum Zitat Liu X, Mills A. Evaluating payment mechanisms: how can we measure unnecessary care? Health Policy Plan. 1999;14(4):409–13.PubMedCrossRef Liu X, Mills A. Evaluating payment mechanisms: how can we measure unnecessary care? Health Policy Plan. 1999;14(4):409–13.PubMedCrossRef
6.
Zurück zum Zitat Hopkins A. What do we mean by appropriate health care? Report of a working group prepared for the director of research and development of the NHS management executive. Qual Health Care. 1993;2(2):117–23.CrossRef Hopkins A. What do we mean by appropriate health care? Report of a working group prepared for the director of research and development of the NHS management executive. Qual Health Care. 1993;2(2):117–23.CrossRef
7.
Zurück zum Zitat The Subspecialty Group of Respiratory Diseases, The Society of Pediatrics, Chinese Medical Association. Guidelines for management of childhood community acquired pneumonia (for trial implementation). Zhonghua Er Ke Za Zhi. 2007;45(2–3):83–90, 223–230. The Subspecialty Group of Respiratory Diseases, The Society of Pediatrics, Chinese Medical Association. Guidelines for management of childhood community acquired pneumonia (for trial implementation). Zhonghua Er Ke Za Zhi. 2007;45(2–3):83–90, 223–230.
8.
Zurück zum Zitat Wagstaff A, O’donnell O, Van doorslaer E, Lindelow M. Analyzing health equity using household survey data: a guide to techniques and their implementation. Washington: World Bank Publications; 2007. Wagstaff A, O’donnell O, Van doorslaer E, Lindelow M. Analyzing health equity using household survey data: a guide to techniques and their implementation. Washington: World Bank Publications; 2007.
9.
Zurück zum Zitat Bonati M. Epidemiologic evaluation of drug use in children. J Clin Pharmacol. 1994;34(4):300–5.PubMed Bonati M. Epidemiologic evaluation of drug use in children. J Clin Pharmacol. 1994;34(4):300–5.PubMed
10.
Zurück zum Zitat Zhang W, Liu X, Wang Y, Chen Y, Huang M, Fan M, et al. Antibiotic use in pulmonology wards of Chinese children’s hospitals: 2002–2006. J Clin Pharm Ther. 2009;34(1):61–5.PubMedCrossRef Zhang W, Liu X, Wang Y, Chen Y, Huang M, Fan M, et al. Antibiotic use in pulmonology wards of Chinese children’s hospitals: 2002–2006. J Clin Pharm Ther. 2009;34(1):61–5.PubMedCrossRef
Metadaten
Titel
Unnecessary use of antibiotics for inpatient children with pneumonia in two counties of rural China
verfasst von
Xiaoyun Liang
Chenggang Jin
Li Wang
Lian Wei
Goran Tomson
Clas Rehnberg
Rolf Wahlstrom
Max Petzold
Publikationsdatum
01.10.2011
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 5/2011
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-011-9535-9

Weitere Artikel der Ausgabe 5/2011

International Journal of Clinical Pharmacy 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.